Inventor · disambiguated record
George L. Trainor
Also filed as: TRAINOR GEORGE · TRAINOR GEORGE L
17 granted patents·9 pending applications·2,563 citations·filing 1990–2022
95Inventor score
Files withDU PONT7BRISTOL MYERS SQUIBB PHARMA CO4BLACK DIAMOND THERAPEUTICS INC3RAPPTA THERAPEUTICS OY3BRISTOL MYERS SQUIBB CO2
Top patents by PatentIndex Score
26 records- 0198US5332666AMethod, system and reagents for DNA sequencingDU PONT·Filed 1991·Granted Jul 26, 1994·302 cites·14 claims
- 0297US5558991ADNA sequencing method using acyclonucleoside triphosphatesDU PONT·Filed 1994·Granted Sep 24, 1996·153 cites·1 claims
- 0397US5470967AOligonucleotide analogs with sulfamate linkagesDU PONT MERCK PHARMA·Filed 1990·Granted Nov 28, 1995·1.5k cites·24 claims
- 0497US5242796AMethod, system and reagents for DNA sequencingDU PONT·Filed 1991·Granted Sep 7, 1993·141 cites·5 claims
- 0595US5608063AMethod, system and reagents for DNA sequencingDU PONT·Filed 1995·Granted Mar 4, 1997·68 cites·3 claims
- 0694US5151507AAlkynylamino-nucleotidesDU PONT·Filed 1991·Granted Sep 29, 1992·381 cites·9 claims
- 0785US11034672B1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·2 cites·29 claims
- 0884US7442700B2Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Oct 28, 2008·5 cites·20 claims
- 0982US8633200B2Inhibitors of human immunodeficiency virus replicationPENDRI ANNAPURNA·Filed 2011·Granted Jan 21, 2014·5 cites·13 claims
- 1082US7045540B2Selective estrogen receptor modulatorsBRISTOL MEYERS SQUIBB CO·Filed 2005·Granted May 16, 2006·4 cites·21 claims
- 1181US6391919B1Bis-amino acid sulfonamides containing substituted benzyl amines HIV protease inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted May 21, 2002·11 cites·24 claims
- 1270US6927224B2Selective estrogen receptor modulatorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Aug 9, 2005·3 cites·9 claims
- 1370US6528681B2Halogenated triphenylethylene derivatives as selective estrogen receptor modulatorsBRISTOL MEYERS SQUIBB PHARMA C·Filed 2001·Granted Mar 4, 2003·5 cites·6 claims
- 1463US5276143ADideoxyfructonucleosides and deoxyfructonucleotidesDU PONT·Filed 1990·Granted Jan 4, 1994·14 cites·3 claims
- 1563US2009062288A1Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithMASTALERZ HAROLD·Filed 2008·Application pending·0 cites
- 1662US5625081AFluorescent dye intermediatesDU PONT·Filed 1994·Granted Apr 29, 1997·5 cites·4 claims
- 1758US2022363666A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1857US7323587B2Selective estrogen receptor modulatorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2005·Granted Jan 29, 2008·0 cites·13 claims
- 1954US6617310B2Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl aminesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Sep 9, 2003·0 cites·30 claims
- 2054US2023020161A1Tricyclic Modulators of PP2ARAPPTA THERAPEUTICS OY·Filed 2021·Application pending·0 cites
- 2152US2023219942A1Compounds comprising a three ring core as pd-1/pd-l1 blockersRELIVE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2251US2020347108A1Peptide Conjugates Incorporating Urea Elements and Their Use as VaccinesSAPVAX LLC·Filed 2020·Application pending·0 cites
- 2348US2010137319A1Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewithBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2445US2024174603A1Modulators of protein phosphatase 2a (pp2a) and methods using sameRAPPTA THERAPEUTICS OY·Filed 2022·Application pending·0 cites
- 2543US2024174611A1Substituted cyclic modulators of protein phosphatase 2a (pp2a) and methods using sameRAPPTA THERAPEUTICS OY·Filed 2022·Application pending·0 cites
- 2641US2022041613A1Tyrosine kinase inhibitor compositions, methods of making and methods of useBLACK DIAMOND THERAPEUTICS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George L. Trainor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →